Mid-day market update: Dow falls 100 points; Can-Fite BioPharma (CANF Stock) shares jump


Midway through trading Tuesday, the Dow traded down 0.33% to 32,844.83 while the NASDAQ rose 0.96% to 13,588.85. The S&P also rose, gaining 0.11% to 3,973.31.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 29,496,140 cases with around 535,650 deaths. Brazil reported over 11,519,600 COVID-19 cases with 279,280 deaths, while India confirmed a total of at least 11,409,830 cases and 158,850 deaths. In total, there were at least 120,338,070 cases of COVID-19 worldwide with more than 2,662,990 deaths, according to data compiled by Johns Hopkins University.

Leading and Lagging Sectors

Communication services shares rose 1.4% on Monday. Meanwhile, top gainers in the sector included Lizhi Inc. LIZI 28.18%, up 31%, and Zedge, Inc. ZDGE 17.06%, up 23%.

In trading on Monday, energy shares fell 2.6%.

Top Headline

Jabil Inc. JBL 2.86% reported better-than-expected results for its second quarter and raised FY21 guidance.

Jabil posted quarterly earnings of $1.27 per share, beating analysts’ estimates of $0.95 per share. The company’s quarterly sales came in at $6.83 billion, exceeding expectations of $6.57 billion.

Equities Trading UP

SunLink Health Systems, Inc. SSY 203.65% shares shot up 190% to $5.59 as the company reported $2 million expansion, capital and operating improvements at Trace Regional Hospital.

Shares of Savara Inc. SVRA 37.01% got a boost, shooting 31% to $2.31 after the company's CFO disclosed an open market purchase of 13,793 shares at $1.45 per share. Piper Sandler initiated coverage on Savara with an Overweight rating and announced a price target of $7.

Can-Fite BioPharma Ltd. CANF 55.44% shares were also up, gaining 49% to $3.0390 after the company announced it has signed a $42.7 million out-licensing deal with Ewopharma. Can-Fite will receive $2.25 million upfront and an additional $40.45 million upon achievement of milestones.

Check out these big movers of the day

Equities Trading DOWN

CleanSpark, Inc. CLSK 22.39% shares tumbled 22% to $22.86 after the company reported pricing of $200 million underwritten public offering.

Shares of Kaspien Holdings Inc. KSPN 27.09% were down 28% to $30.45 after the company reported a bought deal offering of 416,600 shares of common stock at $32.50 per share.

Solid Biosciences Inc. SLDB 29.97% was down, falling 30% to $6.67 after the company reported interim functional, biomarker data, and patient-reported outcome measures from its ongoing IGNITE Phase 1/2 trial of its lead gene therapy candidate, SGT-001 in Duchenne muscular dystrophy (DMD)..

Commodities

In commodity news, oil traded down 1.6% to $64.37, while gold traded down 0.1% to $1,727.90.

Silver traded down 1.2% Tuesday to $25.985 while copper fell 1.5% to $25.985.

Euro zone

European shares were higher today. The eurozone’s STOXX 600 gained 0.88%, the Spanish Ibex Index rose 0.29% and the German DAX 30 gained 0.89%. Meanwhile, the French CAC 40 rose 0.42%, London’s FTSE 100 rose 0.69% and Italy’s FTSE MIB rose 0.57%.

The ZEW Indicator of Economic Sentiment for the Eurozone increased 4.4 points to 74 in March, while the German ZEW Indicator of Economic Sentiment increased by 5.4 points to 76.6 in March. French consumer price inflation rate was revised higher to 0.6% year-over-year in February.

Economics

The Federal Open Market Committee will start its two-day policy meeting today.

Retail sales dropped 3% in February versus a revised 7.6% surge in January.

Import prices rose 1.3% in February, while prices for US exports rose 1.6%.

Industrial production declined 2.2% in February, following a revised 1.1% rise in the previous month.

US business inventories rose 0.3% for January.

The NAHB housing market index dropped 2 points to 82 in March.

Share: Feed news

Benzinga does not provide investment advice. All rights reserved.

Recommended content


Recommended content

Editors’ Picks

EUR/USD consolidates recovery below 1.0700 amid upbeat mood

EUR/USD consolidates recovery below 1.0700 amid upbeat mood

EUR/USD is consolidating its recovery but remains below 1.0700 in early Europe on Thursday. The US Dollar holds its corrective decline amid a stabilizing market mood, despite looming Middle East geopolitical risks. Speeches from ECB and Fed officials remain on tap. 

EUR/USD News

GBP/USD remains capped below 1.2470, eyes on US data

GBP/USD remains capped below 1.2470, eyes on US data

The GBP/USD pair trades on a softer note around 1.2450 on Thursday. The softer UK inflation data prompted the expectation that the Bank of England will start lowering interest rates in the coming months, which weighs on the Pound Sterling against the Greenback. 

GBP/USD News

Gold appears a ‘buy-the-dips’ trade on simmering Israel-Iran tensions

Gold appears a ‘buy-the-dips’ trade on simmering Israel-Iran tensions

Gold price attempts another run to reclaim $2,400 amid looming geopolitical risks. US Dollar pulls back with Treasury yields despite hawkish Fedspeak, as risk appetite returns. Gold confirmed a symmetrical triangle breakdown on 4H but defends 50-SMA support.

Gold News

Manta Network price braces for volatility as $44 million worth of MANTA is due to flood markets

Manta Network price braces for volatility as $44 million worth of MANTA is due to flood markets

Manta Network price was not spared from the broader market crash instigated by a weakness in the Bitcoin market. While analysts call a bottoming out in the BTC price, the Web3 modular ecosystem token could suffer further impact.

Read more

Investors hunkering down

Investors hunkering down

Amidst a relentless cautionary deluge of commentary from global financial leaders gathered at the International Monetary Fund and World Bank Spring meetings in Washington, investors appear to be taking a hiatus after witnessing significant market movements in recent weeks.

Read more

Forex MAJORS

Cryptocurrencies

Signatures